Skip to main content
kainos loboratories,inc logo

kainos loboratories,inc — Investor Relations & Filings

Ticker · 4556 ISIN · JP3205650009 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2024-06-21 Regulatory Filings
Country JP Japan
Listing T 4556

About kainos loboratories,inc

https://www.kainos.co.jp/en/

Kainos Laboratories, Inc. is a company focused on the development, manufacture, marketing, and distribution of in-vitro diagnostics and pharmaceuticals. As a pioneer in its field, the company specializes in creating innovative clinical testing reagents for biochemical, immunological, and genetic analysis. These diagnostic tools are used to examine biological samples, such as blood and urine, to provide data on a patient's health status. The company is committed to developing and supplying novel products to meet the needs of the medical and healthcare communities.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report, should be classified as Regulatory Filings (RNS). FY 2024
2024-06-21 Japanese
有価証券報告書－第49期(2023/04/01－2024/03/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard annual securities report required under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial data, management indicators, and corporate information for the fiscal year ending March 31, 2024. This corresponds to the 10-K filing category in the provided schema. FY 2024
2024-06-21 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document explicitly states "第３四半期報告書" (Third Quarter Report) in the title and header. It confirms the period covered (2023年10月１日 至 2023年12月31日) and references compliance with financial instruments laws ("金融商品取引法"). This structure, focusing on a specific quarterly period and containing confirmation statements regarding the appropriateness of the filing, strongly indicates a comprehensive quarterly financial report, which aligns with the definition of an Interim / Quarterly Report (IR). Although it is a confirmation document related to the report, the core subject matter is the quarterly filing itself, making IR the most appropriate classification over a general RPA or RNS, especially given the detailed period specification.
2024-02-02 Japanese
四半期報告書－第49期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet and income statement for the third quarter, as well as management analysis and notes. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-02-02 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan, which accompanies a Quarterly Report (Dai-ni shihanki hokokusho). Since this is a formal regulatory filing confirming the accuracy of the quarterly report and is not the quarterly report itself, it falls under the category of general regulatory filings.
2023-11-02 Japanese
四半期報告書－第49期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the second quarter of the 49th fiscal period, covering the period from April 1, 2023, to September 30, 2023. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2024
2023-11-02 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.